My Quote Request
6505-01-145-8827
20 Products
NDC00603-3265-21
DICYCLOMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011458827
NSN
6505-01-145-8827
NDC00603-3265-21
DICYCLOMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011458827
NSN
6505-01-145-8827
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DICYCLOMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DICYCLOMINE HYDROCHLORIDE CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,MERRELL-DOW PHARM
Related Searches:
DELTASONE
PREDNISONE TABLETS,USP
NSN, MFG P/N
6505011460539
NSN
6505-01-146-0539
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISONE TABLETS USP 10MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DELTASONE TABLETS
PREDNISONE TABLETS,USP
NSN, MFG P/N
6505011460539
NSN
6505-01-146-0539
DELTASONE TABLETS
PREDNISONE TABLETS,USP
NSN, MFG P/N
6505011460539
NSN
6505-01-146-0539
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISONE TABLETS USP 10MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00009-0193-02
PREDNISONE TABLETS,USP
NSN, MFG P/N
6505011460539
NSN
6505-01-146-0539
NDC00009-0193-02
PREDNISONE TABLETS,USP
NSN, MFG P/N
6505011460539
NSN
6505-01-146-0539
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISONE TABLETS USP 10MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00054-4730-29
PREDNISONE TABLETS,USP
NSN, MFG P/N
6505011460539
NSN
6505-01-146-0539
NDC00054-4730-29
PREDNISONE TABLETS,USP
NSN, MFG P/N
6505011460539
NSN
6505-01-146-0539
MFG
CARDINAL HEALTH 200 LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISONE TABLETS USP 10MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
12-405-055
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011460540
NSN
6505-01-146-0540
12-405-055
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011460540
NSN
6505-01-146-0540
MFG
COBE LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.250 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 105.500 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 137.500 MILLIEQUIVALENTS SODIUM ION PER LITER AND 36 MEQ. ACETATE ION PER LITER AND 0.75 MEQ. MAGNESIUM ION PER LITER
PRIMARY CONTAINER CONTENT QUANTITY: 55.000 GALLONS
PRIMARY CONTAINER TYPE: DRUM
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 34 PARTS WATER
Related Searches:
RENALYTE 12-405
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011460540
NSN
6505-01-146-0540
RENALYTE 12-405
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011460540
NSN
6505-01-146-0540
MFG
COBE LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.250 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 105.500 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 137.500 MILLIEQUIVALENTS SODIUM ION PER LITER AND 36 MEQ. ACETATE ION PER LITER AND 0.75 MEQ. MAGNESIUM ION PER LITER
PRIMARY CONTAINER CONTENT QUANTITY: 55.000 GALLONS
PRIMARY CONTAINER TYPE: DRUM
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 34 PARTS WATER
Related Searches:
NDC00008-0051-02
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011461137
NSN
6505-01-146-1137
NDC00008-0051-02
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011461137
NSN
6505-01-146-1137
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP FOR DOD, WYETH-AYERST LABORATORIES
Related Searches:
NDC00536-4879-01
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011461137
NSN
6505-01-146-1137
NDC00536-4879-01
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011461137
NSN
6505-01-146-1137
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP FOR DOD, WYETH-AYERST LABORATORIES
Related Searches:
SERAX
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011461137
NSN
6505-01-146-1137
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP FOR DOD, WYETH-AYERST LABORATORIES
Related Searches:
SERAX CAPSULES
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011461137
NSN
6505-01-146-1137
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP FOR DOD, WYETH-AYERST LABORATORIES
Related Searches:
NDC00732-1904-12
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505011461138
NSN
6505-01-146-1138
NDC00732-1904-12
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505011461138
NSN
6505-01-146-1138
MFG
PHARMA-SERVE INC TORIGIAN LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS HEPARIN SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00186-0175-14
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION,USP
NSN, MFG P/N
6505011461139
NSN
6505-01-146-1139
NDC00186-0175-14
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION,USP
NSN, MFG P/N
6505011461139
NSN
6505-01-146-1139
MFG
ASTRA PHARMACEUTICALS LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.001 PERCENTAGE, W/V EPINEPHRINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIDOCAINE HYDROCHLORIDE & EPINEPHRINE INJ USP 1.8ML CARTRIDGE 100S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD; FOR DENTAL USE; USE W/SYRINGE 6515-01-010-8761
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.800 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE
SPECIAL FEATURES: EPINEPRINE 1:100,000
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
XYLOCAINE ASTRAPAK
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION,USP
NSN, MFG P/N
6505011461139
NSN
6505-01-146-1139
XYLOCAINE ASTRAPAK
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION,USP
NSN, MFG P/N
6505011461139
NSN
6505-01-146-1139
MFG
ASTRA PHARMACEUTICALS LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.001 PERCENTAGE, W/V EPINEPHRINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIDOCAINE HYDROCHLORIDE & EPINEPHRINE INJ USP 1.8ML CARTRIDGE 100S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD; FOR DENTAL USE; USE W/SYRINGE 6515-01-010-8761
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.800 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE
SPECIAL FEATURES: EPINEPRINE 1:100,000
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
LOXITANE
LOXAPINE HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505011461624
NSN
6505-01-146-1624
LOXITANE
LOXAPINE HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505011461624
NSN
6505-01-146-1624
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS LOXAPINE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
LOXITANE-IM
LOXAPINE HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505011461624
NSN
6505-01-146-1624
LOXITANE-IM
LOXAPINE HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505011461624
NSN
6505-01-146-1624
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS LOXAPINE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00205-5385-55
LOXAPINE HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505011461624
NSN
6505-01-146-1624
NDC00205-5385-55
LOXAPINE HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505011461624
NSN
6505-01-146-1624
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS LOXAPINE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
2F7304
CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION
NSN, MFG P/N
6505011461626
NSN
6505-01-146-1626
2F7304
CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION
NSN, MFG P/N
6505011461626
NSN
6505-01-146-1626
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 430.000 MILLIGRAMS SODIUM CARBONATE, ANHYDROUS ACTIVE INGREDIENT AND 380.000 MILLIGRAMS MAGNESIUM OXIDE ACTIVE INGREDIENT AND 3.24 GRAMS CITRIC ACID HYDROUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: IRRIGATING SOLUTION; IN POUR TYPEPLASTIC BOTTLE WITH BAND AND BAIL; WITHOUT IV TYPE RUBBER STOPPER
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
AQUALITE
CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION
NSN, MFG P/N
6505011461626
NSN
6505-01-146-1626
AQUALITE
CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION
NSN, MFG P/N
6505011461626
NSN
6505-01-146-1626
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 430.000 MILLIGRAMS SODIUM CARBONATE, ANHYDROUS ACTIVE INGREDIENT AND 380.000 MILLIGRAMS MAGNESIUM OXIDE ACTIVE INGREDIENT AND 3.24 GRAMS CITRIC ACID HYDROUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: IRRIGATING SOLUTION; IN POUR TYPEPLASTIC BOTTLE WITH BAND AND BAIL; WITHOUT IV TYPE RUBBER STOPPER
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00074-7168-09
CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION
NSN, MFG P/N
6505011461626
NSN
6505-01-146-1626
NDC00074-7168-09
CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION
NSN, MFG P/N
6505011461626
NSN
6505-01-146-1626
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 430.000 MILLIGRAMS SODIUM CARBONATE, ANHYDROUS ACTIVE INGREDIENT AND 380.000 MILLIGRAMS MAGNESIUM OXIDE ACTIVE INGREDIENT AND 3.24 GRAMS CITRIC ACID HYDROUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: IRRIGATING SOLUTION; IN POUR TYPEPLASTIC BOTTLE WITH BAND AND BAIL; WITHOUT IV TYPE RUBBER STOPPER
TOTAL PRIMARY CONTAINER QUANTITY: 12